Patients with cervical cancer who have lung metastasis can take bevacizumab targeted drug. Bevacizumab is a monoclonal antibody that can inhibit vascular endothelial growth factor and treat various metastatic cancers, so the effect of the drug mainly inhibits the growth of vascular endothelium, which is used to treat cancer with good effect and can inhibit the growth of tumor cells and play a remission role, especially it has a special effect on vascular endothelial factor It can inhibit the growth of tumor cells and provide remission, especially for vascular endothelial factor. Genetic testing can also be performed and other suitable targeted drugs can be selected according to the results. Cervical cancer is a kind of gynecological malignancy that seriously threatens women’s health.